Rapt Therapeutics, Inc. (RAPT)
33.50
-2.34
(-6.53%)
USD |
NASDAQ |
Dec 30, 16:00
33.50
0.00 (0.00%)
After-Hours: 20:00
Rapt Therapeutics Market Cap: 554.02M for Dec. 30, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Replimune Group, Inc. | 769.53M |
| Olema Pharmaceuticals, Inc. | 1.719B |
| NovaBay Pharmaceuticals, Inc. | 772.45M |
| Palatin Technologies, Inc. | 13.39M |
| Theriva Biologics, Inc. | 6.397M |
Market Cap Related Metrics
| PEG Ratio | -0.0115 |
| Price to Book Value | 3.645 |
| Price | 33.50 |
| Earnings Yield | -31.38% |
| PEGY Ratio | -0.0115 |